Latest news
CMPS Stock Climbs After-Hours: Analyst Sees Depression Drug Approval By H1 2027 Or Sooner After Strong Trial Data - StocktwitsStocktwits · Sat, 08 Aug 2026 08:02:26 GMTOTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision - StocktwitsStocktwits · Sat, 08 Aug 2026 07:13:33 GMTGILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment - StocktwitsStocktwits · Fri, 07 Aug 2026 12:09:55 GMTIBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU - StocktwitsStocktwits · Fri, 07 Aug 2026 11:34:22 GMTSPCX, RKLB, ASTS, LUNR In Focus — Trump Administration To Expedite Approvals For Commercial Rocket Launches - StocktwitsStocktwits · Fri, 07 Aug 2026 11:34:15 GMTReplimune’s Melanoma FDA Decision Pending: This Analyst Sees 40% Upside, ‘High Conviction’ For Approval - StocktwitsStocktwits · Fri, 07 Aug 2026 09:30:26 GMTVERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics - StocktwitsStocktwits · Fri, 07 Aug 2026 09:09:07 GMTPRAX Stock Drops 12% After Hours On Trial Setback — Retail Eyes FDA Approval Of Other Pipeline Candidates - StocktwitsStocktwits · Fri, 07 Aug 2026 07:02:44 GMT